Present your work at EAS 2021, Helsinki, Finland
Even while we thank our EAS 2020 faculty and presenters for contributing to the scientific discussion at our recent virtual meeting, we are already looking forward to continuing the conversation at EAS 2021, in Helsinki, Finland (May 30-June 02). The programme for the Plenary sessions is available - we look forward to these presentations from our renowned international faculty, and we now invite clinicians and basic researchers studying atherosclerosis and related vascular disease to submit an abstract of their own research.
Abstracts selected for presentation may subsequently be published in the Society’s internationally recognised Atherosclerosis journal.
Each year EAS Congress enables delegates to exchange knowledge and forge new collaborations. Take the chance to share your work with scientists from all over the world in Helsinki - on the beautiful Baltic seacoast.
Abstract submission for EAS 2021 is open until January 12, 2021.
New EAS Executive Officers & Committee members 2021
We are pleased to announce the new officers & members of EAS Executive Committee 2021:
We welcome them to their new roles, and look forward to their contribution to the development Society's activities.
We appreciate all of the candidates who stood for election for their engagement in the life of the Society.
We also thank Professor Chris Packard, Chair of the Election Committee, and the Election Committee members for their time and diligent efforts in the 2020 election.
In case you missed it...
EAS 2020 Virtual Congress
If you registered for the Virtual EAS Congress (both members & non-members), you can use your registration link to watch the presentations until the end of the year.
EAS-NLA Joint session – Targets & Therapeutic approaches – The EAS way versus the US way
How different – or similar – are European and US lipid guidelines?
This session discussed targets and therapeutic approaches in the two regions.
ESC-EAS Joint session: A deep dive into the 2019 Lipid Guidelines
This Joint Session of the EAS and European Society of Cardiology (ESC) provided an ideal opportunity to delve deeper into the guidelines using a case approach.
Management of dyslipidaemia without apparent coronary artery disease (CAD) was discussed based on two cases.
EAS Members can now view the presentations from EAS Virtual Congress!
The many outstanding lectures, informative discussions and posters can still be viewed by EAS Individual Members - a wealth of fascinating science for you to explore at your own pace.